JOHNSON & JOHNSON — Director's Dealing 2020

Feb 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2020-02-13

Reporting Person: McEvoy Ashley (EVP, WW Chair, Medical Devices)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-13	Common Stock	M	7145.0000	—	Acquired	49894.1929	Direct
2020-02-13	Common Stock	M	6602.0000	—	Acquired	56496.1929	Direct
2020-02-13	Common Stock	F	2801.0000	$150.4600	Disposed	53695.1929	Direct
2020-02-13	Common Stock	F	3031.0000	$150.4600	Disposed	50664.1929	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-13	Performance Share Units	$	M	7145.0000	Disposed		Common Stock (7145.0000)	Direct
2020-02-13	Restricted Share Units	$	M	6602.0000	Disposed		Common Stock (6602.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2370.0000	Indirect
Common Stock	300.0000	Indirect

Footnotes

F1: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting.

F2: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting.

F3: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

F4: Shares withheld for payment of taxes upon vesting of Performance Share Units.

F5: Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2020).

F6: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2020).